Send us Feedback

EPIX Pharmaceuticals (EPIX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EPIX » Topics » Nominating and Governance Committee

This excerpt taken from the EPIX DEF 14A filed Apr 24, 2009.
Nominating and Governance Committee
 
The nominating and governance committee of the board of directors currently consists of Michael Gilman, Ph.D., Mark Leuchtenberger and Gregory D. Phelps (Chairman). Each of the current members is an independent director within the meaning of the director independence standards of NASDAQ.
 
The nominating and governance committee’s responsibilities include:
 
  •  assisting the board by identifying qualified candidates for director and recommending to the board the director nominees for the next annual meeting of stockholders;
 
  •  leading the board in its annual review of the board’s performance;
 
  •  recommending to the board director nominees for each board committee;
 
  •  overseeing the annual process of evaluation of the performance of our management; and
 
  •  developing and recommending to the board a set of corporate governance guidelines.
 
The nominating and governance committee met two times during the fiscal year ended December 31, 2008. The nominating and governance committee operates under a written charter adopted by the board of directors, a current copy of which is available at the Corporate Governance section of our website at http://www.epixpharma.com.
 
This excerpt taken from the EPIX DEF 14A filed Apr 1, 2008.
Nominating and Governance Committee
 
The nominating and governance committee of the board of directors currently consists of Michael Gilman, Ph.D., Mark Leuchtenberger and Gregory D. Phelps (Chairman). In June 2007, Dr. Gilman replaced Frederick Frank on this committee. Each of the current members is an independent director within the meaning of the director independence standards of NASDAQ.
 
The nominating and governance committee’s responsibilities include:
 
  •  assisting the board by identifying qualified candidates for director and recommending to the board the director nominees for the next annual meeting of stockholders;
 
  •  leading the board in its annual review of the board’s performance;
 
  •  recommending to the board director nominees for each board committee;
 
  •  overseeing the annual process of evaluation of the performance of our management; and
 
  •  developing and recommending to the board a set of corporate governance guidelines.
 
The nominating and governance committee met three times during the fiscal year ended December 31, 2007. The nominating and governance committee operates under a written charter adopted by the board of directors, a current copy of which is available at the Corporate Governance section of the Company’s website at http://www.epixpharma.com.
 
This excerpt taken from the EPIX DEF 14A filed Apr 30, 2007.
Nominating and Governance Committee
 
The nominating and governance committee of the board of directors currently consists of Frederick Frank, Mark Leuchtenberger and Gregory D. Phelps (Chairman), each of whom is an independent director within the meaning of the director independence standards of NASDAQ and applicable rules of the SEC.
 
The nominating and governance committee’s responsibilities include:
 
  •  assisting the board by identifying qualified candidates for director and recommending to the board the director nominees for the next annual meeting of stockholders;
 
  •  leading the board in its annual review of the board’s performance;
 
  •  recommending to the board director nominees for each board committee;
 
  •  overseeing the annual process of evaluation of the performance of our management; and
 
  •  developing and recommending to the board a set of corporate governance guidelines.
 
The nominating and governance committee met one time during the fiscal year ended December 31, 2006. The nominating and governance committee operates under a written charter adopted by the board of directors, a current copy of which is available at the Corporate Governance section of the Company’s website at http://www.epixpharma.com.
 

EXCERPTS ON THIS PAGE:

DEF 14A
Apr 24, 2009
DEF 14A
Apr 1, 2008
DEF 14A
Apr 30, 2007

RELATED TOPICS for EPIX:

"Nominating and Governance Committee" elsewhere:

Dyax (DYAX)
Halozyme Therapeutics (HALO)
XOMA (XOMA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki